Related Experiment Video
Updated: Apr 20, 2026

04:14
Author Spotlight: Recent Advancements in Reoperative Foregut Surgery
Published on: September 22, 2023
1.0K
[Stress ulcer after tonsillectomy and adenoidectomy: one case report]
Summary
A child developed a gastric ulcer with bleeding after adenoidectomy. Prompt medical intervention successfully controlled the hemorrhage and led to a full recovery.
Area of Science:
- Pediatric Surgery
- Gastroenterology
- Anesthesiology
Background:
- Chronic tonsillitis and adenoid hypertrophy are common pediatric conditions often treated with adenotonsillectomy.
- General anesthesia is routinely used for pediatric surgical procedures.
Observation:
- An 11-year-old child presented with abdominal discomfort, pallor, and vomiting of dark material post-adenotonsillectomy.
- Initial blood work revealed significant anemia.
Findings:
- Emergency gastroscopy identified a bleeding gastric ulcer as the cause of the symptoms.
- Supportive therapy effectively managed the hemorrhage and corrected the anemia.
Implications:
- This case highlights a rare but serious gastrointestinal complication following adenotonsillectomy.
- Early diagnosis and management are crucial for favorable outcomes in pediatric post-operative bleeding.
- Further research may explore potential links between surgical stress and gastric ulcer formation in children.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
1.3K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
1.3K
Tonsillitis II: Management
639
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
639
Peptic Ulcer Disease III: Clinical Manifestations and Complications
17
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
17
Peptic Ulcer Disease IV: Management
725
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
725
Peptic Ulcer Disease II: Pathophysiology
22
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
22
Peptic Ulcer Disease II: Pathophysiology
3.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
3.0K

